Palvella Therapeutics Inc (PVLA)

Finanzdaten der Palvella Therapeutics Inc-Aktie (PVLA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	44.09%21.41	14.86	11.30	10.18	9.25
Research and Development	33.63%12.47	9.33	7.12	6.53	5.12
Operating Income/Loss	44.09%-21.41	-14.86	-11.30	-10.18	-9.25
Net Interest Income/Expense	83.13%1.97	1.07	0.52	0.63	0.69
Income/Loss From Continuing Operations Before Tax	38.71%-21.87	-15.77	-12.71	-11.35	-9.47
Income Tax Expense/Benefit	-	-	-	-	-
	38.71%-21.87	-15.77	-12.71	-11.35	-9.47
Attributable To Parent	38.71%-21.87	-15.77	-12.71	-11.35	-9.47
Basic Average Shares	9.71%14.36	13.09	-	11.06	11.05
Diluted Average Shares	9.71%14.36	13.09	-	11.06	11.05
Basic Earnings Per Share	26.67%-1.52	-1.20	-	-1.03	-0.86
Diluted Earnings Per Share	26.67%-1.52	-1.20	-	-1.03	-0.86